All for Joomla
All for Webmasters
Hemostasis
Acute Care Diagnostics
Autoimmunity
Transfusion
Transplant
#GiveToGain
WTDay
Cyber Health
EEMEA Learning Center - CTO
Novel Biological Roles of Von Willebrand Factor
Read more...
The urgent need to implement patient blood management: policy brief
Read more...
Factor XIII levels, clot strength, and impact of fibrinogen concentrate in infants undergoing cardiopulmonary bypass: a mechanistic sub-study of the FIBCON trial
Read more...
Rotational thromboelastometry in children presenting to an Australian major trauma centre: A retrospective cohort study
Read more...
A look into hemostatic characteristics during pediatric liver transplantation using the thromboelastometry (ROTEM® ) test
Read more...
Intraoperative transfusion management, antifibrinolytic therapy, coagulation monitoring and the impact on short-term outcomes after liver transplantation-A systematic review of the literature and expert panel recommendations
Read more...
Monitoring of COVID-19-Associated Coagulopathy and Anticoagulation with Thromboelastometry
Read more...
Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study
Read more...
Variations and obstacles in the use of coagulation factor concentrates for major trauma bleeding across Europe: outcomes from a European expert meeting
Read more...
Analytical performance evaluation of the new GEM® Premier™ 5000 analyzer in comparison to the GEM® Premier™ 4000 and the RapidPoint® 405 systems
Read more...
Reduction of thromboembolic complications during the endovascular treatment of unruptured aneurysms by employing a tailored dual antiplatelet regimen using aspirin and prasugrel
Read more...
The utility of platelet inhibition testing in patients undergoing Pipeline embolization of intracranial aneurysms
Read more...
High On-Treatment Platelet Reactivity as Predictor of Long-term Clinical Outcomes in Stroke Patients with Antiplatelet Agents
Read more...
Clopidogrel Resistance in Patients With Stroke Recurrence Under Single or Dual Antiplatelet Treatment
Read more...
D3 - Session 5 - D-Dimer and Arterial Diseases
Read more...
D3 - Session 4 - D-Dimer in Cancer and VTE
Read more...
D3 - Session 3 - Analytical Aspects of D-Dimer Assays
Read more...
D3 - Session 2 - General Overview of Fibrinolysis
Read more...
D3 - Session 1 - Covid19 Associated Coagulopathies: A Year in Review
Read more...
Pre-procedure P2Y12 reaction units value predicts perioperative thromboembolic and hemorrhagic complications in patients with cerebral aneurysms treated with the Pipeline Embolization Device
Read more...
Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneury
Read more...
Last-recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the pipeline embolization device
Read more...
Thromboembolic complications with Pipeline Embolization Device placement: impact of procedure time, number of stents and pre-procedure P2Y12 reaction unit (PRU) value
Read more...
Efficacy of a two-test protocol for achieving a therapeutic response to clopidogrel prior to elective endovascular intracranial aneurysm treatment and an 'induced' postoperative hyper-response
Read more...
Association between CYP2C9 polymorphisms and ischemic stroke following endovascular neurointervention
Read more...
Risk Factor Analysis of Delayed Intracerebral Hemorrhage After Coil Embolization of Unruptured Cerebral Aneurysms
Read more...
2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations
Read more...
Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collabo
Read more...
STS/SCA/AmSECT Clinical Practice Guidelines: Anticoagulation during Cardiopulmonary Bypass
Read more...
Use of an objective tool to assess platelet inhibition prior to off-pump coronary surgery to reduce blood usage
Read more...
Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration
Read more...
High versus standard clopidogrel loading in patients undergoing carotid artery stenting prior to cardiac surgery to assess the number of microemboli detected with transcranial Doppler: results of the randomized IMPACT trial
Read more...
Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery
Read more...
Posttreatment platelet reactivity on clopidogrel is associated with the risk of adverse events after off-pump coronary artery bypass
Read more...
Reduced Effect of Aspirin and Clopidogrel Following Hybrid Coronary Revascularization
Read more...
Monitoring platelet reactivity during prasugrel or ticagrelor washout before urgent coronary artery bypass grafting
Read more...
The absorption of aspirin is reduced after coronary artery bypass grafting
Read more...
Is There a Role for Preoperative Platelet Function Testing in Patients Undergoing Cardiac Surgery During Antiplatelet Therapy?
Read more...
Weight as an assay-independent predictor of poor response to enteric aspirin in cardiovascular patients
Read more...
Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
Read more...
Novel Use of Cangrelor With Heparin During Cardiopulmonary Bypass in Patients With Heparin-Induced Thrombocytopenia Who Require Cardiovascular Surgery: A Case Series
Read more...
Platelet Activity Measured by VerifyNow® Aspirin Sensitivity Test Identifies Coronary Artery Bypass Surgery Patients at Increased Risk for Postoperative Bleeding and Transfusion
Read more...
Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
Read more...
Influence of Valve Type and Antiplatelet Regimen on Platelet Reactivity After TAVI: Subanalysis of the REAC-TAVI Trial
Read more...
Open-label multicenter registry on the outcomes of peripheral arterial disease treated by balloon angioplasty with optical frequency domain imaging in superficial femoral artery and popliteal artery (OCEAN-SFA study)
Read more...
The effect of antiplatelet drug on coronary endothelial and microvascular function: comparison with ticagrelor and clopidogrel
Read more...
Validation of the ABCD-GENE score to identify high platelet reactivity in east Asian patients undergoing percutaneous coronary intervention
Read more...
2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations
Read more...
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the Euro
Read more...
2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery
Read more...
The challenges of diagnosing heparin-induced thrombocytopenia in patients with COVID-19
Read more...
Role of von Willebrand Factor and ADAMTS-13 in the Pathogenesis of Thrombi in SARS-CoV-2 Infection: Time to Rethink
Read more...
D-dimer Triage for COVID-19
Read more...
Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis
Read more...
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis
Read more...
Heparin induced thrombocytopenia antibodies in Covid‐19
Read more...
Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus
Read more...
Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility
Read more...
Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence
Read more...
Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2
Read more...
Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19
Read more...
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
Read more...
Heparin-induced thrombocytopenia with thrombosis in COVID-19 adult respiratory distress syndrome
Read more...
Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis
Read more...
Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort
Read more...
Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolism
Read more...
The vascular side of COVID-19 disease. Position paper of the International Union of Angiology
Read more...
Hematological findings and complications of COVID-19
Read more...
COVID-19-associated coagulopathy: An exploration of mechanisms
Read more...
D-dimer and mortality in COVID-19: a self-fulfilling prophecy or a pathophysiological clue?
Read more...
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Read more...
Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
Read more...
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
Read more...
D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19
Read more...
Response to "All these D-dimers in COVID-19"
Read more...
Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology
Read more...
Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications
Read more...
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors
Read more...
Fibrinolytic therapy for refractory COVID‐19 acute respiratory distress syndrome: Scientific rationale and review
Read more...
In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation
Read more...
Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays
Read more...
Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis
Read more...
Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients
Read more...
The contact activation system as a potential therapeutic target in patients with COVID‐19
Read more...
Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients
Read more...
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
Read more...
Consumptive Coagulopathy and Thrombosis during Severe COVID-19 Infection: Potential Involvement of VWF/ADAMTS13
Read more...
ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients
Read more...
Genomewide Association Study of Severe Covid-19 with Respiratory Failure
Read more...
First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study
Read more...
Protamine overdose and its impact on coagulation, bleeding, and transfusions after cardiopulmonary bypass: results of a randomized double-blind controlled pilot study
Read more...
Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery
Read more...
Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial
Read more...
Point-of-Care Hemostatic Testing in Cardiac Surgery: A Stepped-Wedge Clustered Randomized Controlled Trial
Read more...
Cost Analysis of Transfusion Therapy in Coronary Artery Surgery
Read more...
Viscoelastic Blood Tests Use in Adult Cardiac Surgery: Meta-Analysis, Meta-Regression, and Trial Sequential Analysis
Read more...
Thrombelastometry guided blood-component therapy after cardiac surgery: a randomized study
Read more...
Why does a point of care guided transfusion algorithm not improve blood loss and transfusion practice in patients undergoing high-risk cardiac surgery? A prospective randomized controlled pilot study
Read more...
Combined Use of Rotational Thromboelastometry (Rotem) and Platelet Impedance Aggregometry (Multiplate Analyzer) in Cyanotic and Acyanotic Infants and Children Undergoing Cardiac Surgery With Cardiopulmonary Bypass: Subgroup Analysis of a Randomized C
Read more...
Start
Prev
1
2
Next
End
Page 1 of 2
Werfen.com.
All rights Reserved.
Privacy Policy
|
Cookies Policy
|
Terms of Service
No Internet Connection